By: Angela Garrity
Marijuana Moment is reporting that Senate Majority Leader, Mitch McConnell, has inserted language into a congressional spending report that calls on the FDA to clear a path for the lawful marketing of hemp-derived CBD products.
FDA has stated that allowing CBD to be sold as food items or dietary supplements would require the agency to develop alternative regulations that could take years to complete without congressional action. But McConnell, who was the chief proponent of a hemp legalization provision of the 2018 Farm Bill, isn’t interested in a delay.
In draft language shared by the U.S. Hemp Roundtable today, the senator is asking FDA to “issue a policy of enforcement discretion with regard to certain products containing CBD” within 120 days—a move that industry stakeholders state will clarify rules, which will allow banks to better serve CBD companies.
The provision of the spending report will be marked up in the Senate Appropriations Subcommittee on Agriculture today. It will then go before the full Appropriations Committee on Thursday.
Prior to issuing its enforcement discretion policy under McConnell’s report amendment, FDA would have to submit a report to the committee within 90 days with details of its “progress toward obtaining and analyzing data to help determine a policy of enforcement discretion, and the process in which CBD meeting the definition of hemp will be evaluated for use in products.”
Once those provisional enforcement guidelines are established, they would remain in place until FDA finalizes the regulatory process.
USDA is expected to soon release its broader hemp regulations soon.
Read the full story here.